Historical salary details - Dr. Mark R. Dybul, M.D., Executive Vice Chairman of the Board and Chief Executive Officer, Renovaro Biosciences Inc
Dr. Mark R. Dybul, M.D. has been the Executive Vice Chairman of the Board and Chief Executive Officer of Renovaro Biosciences Inc since 23 Nov 2018. View his historical salary.
Dr. Mark R. Dybul, M.D.
Executive Vice Chairman of the Board and Chief Executive Officer
-
Gross Remuneration
-
Current Company
Renovaro Biosciences Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Renovaro Biosciences Inc | Executive Vice Chairman of the Board and Chief Executive Officer | - | - |
| 2024 | Renovaro Biosciences Inc | Executive Vice Chairman of the Board and Chief Executive Officer | - | - |
| 2023 | Renovaro Biosciences Inc | Executive Vice Chairman of the Board and Chief Executive Officer | 1.4 M | -86.9 % |
| 2022 | Renovaro Biosciences Inc | Executive Vice Chairman of the Board and Principal Executive Officer | 10.8 M | 2400.2 % |
| 2021 | Renovaro Biosciences Inc | - | 430 K | -65.9 % |
| 2021 | Renovaro Biosciences Inc | Executive Vice Chairman of the Board and Principal Executive Officer | 430 K | -65.9 % |
| 2020 | Renovaro Biosciences Inc | - | 1.3 M | -33.2 % |
| 2020 | Renovaro Biosciences Inc | - | 1.3 M | -33.2 % |
| 2020 | Renovaro Biosciences Inc | Executive Vice Chairman of the Board and Principal Executive Officer | 1.3 M | -33.2 % |
| 2019 | Renovaro Biosciences Inc | Executive Vice Chairman of the Board and Principal Executive Officer | 2.0 M | 2468.1 % |
| 2019 | Renovaro Biosciences Inc | - | 1.9 M | 2369.6 % |
| 2019 | Renovaro Biosciences Inc | - | 1.9 M | 2369.6 % |
| 2018 | Renovaro Biosciences Inc | - | 76.5 K | - |
| 2018 | Renovaro Biosciences Inc | - | 76.5 K | - |